Fresh Wind Biotechnologies is a verified, venture-backed clinical-stage company (approx. $10M funding) developing legitimate TIL-based cancer immunotherapies with a credible scientific team. However, the submission itself is of very low quality, containing factually incorrect claims (e.g., 'most people have used my product', audience is 'everyone') and confusing data. While the underlying technology and business are promising and high-utility, the score is heavily penalized by the poor reliability of the submitted information.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline